Transcriptional Regulation of Pancreas Development and Function
Transcriptional Regulation of Pancreas Development and Function
批准号:
8092852
负责人:
CATHERINE LEE MAY
金额:
$32.26万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2013-06-30
关键词:
AblationAddressAdultAffectAllelesAnimalsApoptosisBindingBiochemicalBiological AssayBirthCalciumCell DeathCell Differentiation processCell MaintenanceCell physiologyCellsCellular biologyCongenital Heart DefectsConsensusDataDevelopmentDiabetes MellitusDiabetes preventionDifferentiation and GrowthDiseaseElementsEmbryoEndocrineFive-Year PlansGelGene ExpressionGenesGeneticGenetic TranscriptionGlucoseGrowth and Development functionHealthHyperglycemiaImageIn VitroInsulinIslet CellIslets of LangerhansKnockout MiceLeadLinkMaintenanceMediatingMessenger RNAMetabolic DiseasesModelingMolecularMusMutationNeonatalPancreasPatternPhenotypePhysiologicalPlasmaPlayPrimitive foregut structureProductionRegulationReplacement TherapyReporterRoleSiteStagingTestingTimeTranscriptional Regulationbasecell growthchromatin immunoprecipitationdiabeticenhancer binding proteinfunctional losshomeodomainin vitro Assayinsulin secretionisletknockout animalmouse modelnovel therapeuticspancreas developmentpostnatalpreventpromoterresearch studytranscription factor
中文摘要
描述(由申请人提供):所有形式的糖尿病的共同点是内分泌胰腺中功能性胰岛素产生细胞的逐渐丧失。了解内分泌胰腺的发育和功能是开发这种疾病新疗法的基础。遗传学研究表明,转录因子在调节细胞的建立和维持中起着至关重要的作用。Islet-1(Isl-1)是一种在胚胎前肠和成年胰岛细胞中表达的含有同源结构域的转录因子,对早期内分泌细胞分化至关重要。然而,由于Isl-1缺陷小鼠的早期胚胎致死性,Isl-1在调节细胞生长、存活和功能中的作用尚未得到解决。在过去的一年中,我们已经取得了重大进展,我们的理解Isl-1在第二波内分泌细胞分化使用Pdx 1-Cre/Isl-1/LoxP/LoxP小鼠。在接下来的五年里,我们计划利用诱导型小鼠模型研究Isl-1在更具体的发育阶段的作用。我们假设Isl-1是出生后<$-细胞生长和/或存活以及功能所必需的,并且在<$-细胞中通过直接激活MafA和胰岛素转录来调节MafA和胰岛素表达。在目标1和3中,我们将使用诱导型小鼠模型专门测试Isl-1在新生儿<$-细胞重塑和成年<$-细胞功能期间的作用。目的2探讨Isl-1调控MafA和Insulin基因表达的分子机制。这些数据将进一步加深我们对细胞生物学的理解,并可能导致治疗糖尿病的新疗法。公共卫生相关性:糖尿病是一种代谢紊乱,目前影响全球超过1.8亿人。更换丢失或功能不正常的设备
细胞代表了治愈、治疗或预防糖尿病的最佳可能性。本申请中描述的实验将有助于描述控制细胞生长和发育的机制,并使我们更接近于产生用于细胞替代疗法的功能性细胞。
英文摘要
DESCRIPTION (provided by applicant): Common to all forms of diabetes is the gradual loss of functional insulin-producing ¿-cells in the endocrine pancreas. Understanding the development and function of the endocrine pancreas is fundamental to the development of novel therapeutics for this disease. Genetic studies have revealed that transcription factors play an essential role in regulating the establishment and maintenance of ¿-cells. Islet-1 (Isl-1), a homeo- domain containing transcription factor expressed in embryonic foregut and later in adult islet cells, is essential for early endocrine cell differentiation. However, because of the early embryonic lethality of Isl-1 deficient mice, the roles of Isl-1 in the regulation of ¿-cell growth, survival and function have not been addressed. In the past year, we have made significant progress to our understanding of the role of Isl-1 during second wave of endocrine cell differentiation using the Pdx1-Cre/Isl-1/LoxP/LoxP mice. Over the next five years we plan to investigate the role of Isl-1 at more specific developmental stages utilizing an inducible mouse model. We hypothesize that Isl-1 is required for postnatal ¿-cell growth and/or survival as well as function and is required in ¿-cells to regulate MafA and Insulin expression through direct activation of MafA and Insulin transcription. In Aim 1 and 3, we will specifically test the role of Isl-1 during neonatal ¿-cell remodeling and during adult ¿-cell function using an inducible mouse model. Aim 2 will determine the molecular mechanism by which Isl-1 regulates MafA and Insulin gene expression. These data will further our understanding of ¿-cell biology and may lead to novel therapeutics for the treatment of diabetes mellitus. PUBLIC HEALTH RELEVANCE: Diabetes mellitus is a metabolic disorder that currently affects over 180 million people worldwide. Replacement of lost or improperly functioning
¿-cells represents the best possibility to cure, treat, or prevent diabetes. The experiments described in this application will help delineate the mechanisms controlling the growth and development of ¿-cells and bring us closer to generating functional ¿-cells for cell replacement therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcriptional regulation of pancreas development and function
-
批准号:7993194
-
项目类别:
-
资助金额:$14.46万
-
财政年份:2010
-
负责人:CATHERINE LEE MAY
-
依托单位:
Transcriptional regulation of pancreas development and function
-
批准号:7880864
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2008
-
负责人:CATHERINE LEE MAY
-
依托单位:
Transcriptional Regulation of Pancreas Development and Function
-
批准号:8282934
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2008
-
负责人:CATHERINE LEE MAY
-
依托单位:
Transcriptional regulation of pancreas development and function
-
批准号:7612103
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2008
-
负责人:CATHERINE LEE MAY
-
依托单位:
Transcriptional regulation of pancreas development and function
-
批准号:7816348
-
项目类别:
-
资助金额:$82.09万
-
财政年份:2008
-
负责人:CATHERINE LEE MAY
-
依托单位:
Transcriptional Regulation of Pancreas Development and Function
-
批准号:7433453
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2007
-
负责人:CATHERINE LEE MAY
-
依托单位:
The Role of Neurogenin 3 in Pancreas Development
-
批准号:6694789
-
项目类别:
-
资助金额:$4.89万
-
财政年份:2002
-
负责人:CATHERINE LEE MAY
-
依托单位:
The Role of Neurogenin 3 in Pancreas Development
-
批准号:6622342
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2002
-
负责人:CATHERINE LEE MAY
-
依托单位:
The Role of Neurogenin 3 in Pancreas Development
-
批准号:6445345
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2002
-
负责人:CATHERINE LEE MAY
-
依托单位:
海外基金